The Human Milk Oligosaccharides (HMOs) in Infant Formula market was valued at USD 115.24 Billion in 2022 and is expected to reach USD 540.12 Billion by 2030, growing at a CAGR of 21.3% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.